Discussion
A $2.5 million research grant from The Michael J. Fox Foundation (MJFF) will help expand a Phase 2 clinical study testing the experimental treatment NEU-411 in people with early Parkinson’s disease. Neuron23 will use the funds to activate four clinical sites in Israel for the Phase…
